Bucillamine (International)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
M01CC02
CAS registry number (Chemical Abstracts Service)
0065002-17-7
Chemical Formula
C7-H13-N-O3-S2
Molecular Weight
223
Therapeutic Categories
Antirheumatic agent
Immunomodulator
Chemical Name
N-(2-mercapto-2-metylpropionyl)-L-cysteine (WHO)
Foreign Names
- Bucillaminum (Latin)
- Bucillamin (German)
- Bucillamine (French)
- Bucilamina (Spanish)
Generic Names
- Bucillamine (OS: JAN)
- SA 96 (IS)
- UNII-R80LRA5WTF (IS)
- Bucillamine (PH: JP XVII)
Brand Names
- Bucilant
Kobayashi Kako, Japan - Bucillamine
Nichi-Iko Pharmaceutical, Japan; Towa Yakuhin, Japan - Lemalc
Takeda Teva Pharma, Japan - Rimatil
Ayumi Pharmaceutical, Japan
Glossary
Term | Definition |
---|---|
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
WHO | World Health Organization |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.